A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

2025-09-12/02-06 世界で初のCRISPR-Cas9遺伝子編集ウマが誕生 ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

米国立衛生研究所（NIH）主導の下、ヒトゲノムの全塩基配列解読を目指して1990年に始まったヒトゲノム計画は、2003年に完了した。この、史上最大の生物学共同プロジェクトは、ゲノム学の新たな時代を切り開き、法医学から人類学、DNA検査、そしてハンチントン病などの遺伝病治療まで、数えきれないほど多くの分野において変革を起こした。（参考記事： 「ヒトゲノム解読から10周年」 ） ...

CRISPR became big in 2025, bringing advances for serious Indian health risks, which will continue in the coming year ...

CRISPR Therapeutics (CRSP) shares closed at US$53.77 on Friday, with recent returns mixed, including a 2.5% gain over the past day but a weaker pattern over the month and the past 3 months. See our ...